10 Small–Cap Stocks Insiders Are Buying Recently

8. Phreesia, Inc. (NYSE:PHR)

On March 24, 2026, Mizuho analyst Steven Valiquette lowered the price target on Phreesia, Inc. (NYSE:PHR) to $19 from $22 previously and maintained an Outperform rating ahead of the company’s fiscal Q4 report on March 30. Steven Valiquette said the firm is taking a more conservative approach to estimates following peer earnings reports.

On March 16, 2026, Phreesia, Inc. (NYSE:PHR) announced it refinanced its existing bridge loan by entering into a new credit agreement for a senior secured revolving credit facility of up to $275M, with Capital One serving as agent. The company borrowed about $92.2M at closing to repay all outstanding obligations under the bridge loan, which was terminated without penalty, and said remaining capacity may be used for working capital, capital expenditures, acquisitions, and other general corporate purposes.

Last month, JPMorgan analyst Alexei Gogolev lowered the price target on Phreesia, Inc. (NYSE:PHR) to $24 from $29 previously and maintained an Overweight rating.

Phreesia, Inc. (NYSE:PHR) provides a SaaS-based software and payment platform for healthcare providers in North America.